These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 21535995

  • 1. A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study.
    Zanarini MC, Schulz SC, Detke HC, Tanaka Y, Zhao F, Lin D, Deberdt W, Kryzhanovskaya L, Corya S.
    J Clin Psychiatry; 2011 Oct; 72(10):1353-62. PubMed ID: 21535995
    [Abstract] [Full Text] [Related]

  • 2. Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study.
    Schulz SC, Zanarini MC, Bateman A, Bohus M, Detke HC, Trzaskoma Q, Tanaka Y, Lin D, Deberdt W, Corya S.
    Br J Psychiatry; 2008 Dec; 193(6):485-92. PubMed ID: 19043153
    [Abstract] [Full Text] [Related]

  • 3. Open-label treatment with olanzapine for patients with borderline personality disorder.
    Zanarini MC, Schulz SC, Detke H, Zhao F, Lin D, Pritchard M, Deberdt W, Fitzmaurice G, Corya S.
    J Clin Psychopharmacol; 2012 Jun; 32(3):398-402. PubMed ID: 22544004
    [Abstract] [Full Text] [Related]

  • 4. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial.
    Bozzatello P, Rocca P, Uscinska M, Bellino S.
    CNS Drugs; 2017 Sep; 31(9):809-819. PubMed ID: 28741044
    [Abstract] [Full Text] [Related]

  • 6. Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial.
    Kryzhanovskaya L, Schulz SC, McDougle C, Frazier J, Dittmann R, Robertson-Plouch C, Bauer T, Xu W, Wang W, Carlson J, Tohen M.
    J Am Acad Child Adolesc Psychiatry; 2009 Jan; 48(1):60-70. PubMed ID: 19057413
    [Abstract] [Full Text] [Related]

  • 7. Comparison of low and moderate dosages of extended-release quetiapine in borderline personality disorder: a randomized, double-blind, placebo-controlled trial.
    Black DW, Zanarini MC, Romine A, Shaw M, Allen J, Schulz SC.
    Am J Psychiatry; 2014 Nov 01; 171(11):1174-82. PubMed ID: 24968985
    [Abstract] [Full Text] [Related]

  • 8. Olanzapine versus placebo in the treatment of borderline personality disorder.
    Bogenschutz MP, George Nurnberg H.
    J Clin Psychiatry; 2004 Jan 01; 65(1):104-9. PubMed ID: 14744178
    [Abstract] [Full Text] [Related]

  • 9. Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial.
    Kulkarni J, Thomas N, Hudaib AR, Gavrilidis E, Grigg J, Tan R, Cheng J, Arnold A, Gurvich C.
    CNS Drugs; 2018 Feb 01; 32(2):179-187. PubMed ID: 29549516
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 01; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 11. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.
    Detke HC, DelBello MP, Landry J, Usher RW.
    J Am Acad Child Adolesc Psychiatry; 2015 Mar 01; 54(3):217-24. PubMed ID: 25721187
    [Abstract] [Full Text] [Related]

  • 12. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S.
    J Affect Disord; 2008 Jan 01; 105(1-3):101-8. PubMed ID: 17531327
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study.
    Katagiri H, Tohen M, McDonnell DP, Fujikoshi S, Case M, Kanba S, Takahashi M, Gomez JC.
    BMC Psychiatry; 2013 May 14; 13():138. PubMed ID: 23672672
    [Abstract] [Full Text] [Related]

  • 14. Olanzapine versus placebo in the treatment of adolescents with bipolar mania.
    Tohen M, Kryzhanovskaya L, Carlson G, Delbello M, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Robertson-Plouch C, Xu W, Dittmann RW, Biederman J.
    Am J Psychiatry; 2007 Oct 14; 164(10):1547-56. PubMed ID: 17898346
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.
    Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson GD, Breier A.
    Arch Gen Psychiatry; 2000 Sep 14; 57(9):841-9. PubMed ID: 10986547
    [Abstract] [Full Text] [Related]

  • 16. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology.
    Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J.
    J Pers Disord; 2003 Jun 14; 17(3):233-42. PubMed ID: 12839102
    [Abstract] [Full Text] [Related]

  • 17. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study.
    Zanarini MC, Frankenburg FR.
    J Clin Psychiatry; 2001 Nov 14; 62(11):849-54. PubMed ID: 11775043
    [Abstract] [Full Text] [Related]

  • 18. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.
    J Clin Psychiatry; 2009 Oct 14; 70(10):1424-31. PubMed ID: 19906346
    [Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania.
    Van Ameringen M, Mancini C, Patterson B, Bennett M, Oakman J.
    J Clin Psychiatry; 2010 Oct 14; 71(10):1336-43. PubMed ID: 20441724
    [Abstract] [Full Text] [Related]

  • 20. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun 14; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.